Retatrutide 48mg

Retatrutide 48 mg – High-Dose Triple Agonist Peptide for Metabolic Research

Retatrutide 48 mg is a powerful, research-grade peptide that functions as a triple hormone receptor agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This high-dose formulation is specifically developed for advanced metabolic and endocrine research, offering extended flexibility for dose-ranging, long-term, and high-volume studies.

Retatrutide 48mg Combining the effects of three metabolic pathways, Retatrutide has demonstrated promising potential in preclinical and clinical studies related to:

• Obesity and weight management

• Type 2 diabetes and insulin resistance

• Appetite regulation and energy expenditure

• Fat metabolism and glucose control

Key Features: Retatrutide 48mg

• 48 mg high-dose format – ideal for extended or high-demand research applications

• Triple agonist action for comprehensive metabolic pathway engagement

• Lyophilized for stability and ease of storage

• ≥98% purity (HPLC-verified) for reliable, reproducible results

• Suitable for both in vitro and in vivo research models

Product Specifications:

• Name: Retatrutide

• Dosage: 48 mg

• Form: Lyophilized powder

• Purity: ≥98%

• Storage: -20°C; keep dry and protected from light

• Reconstitution: Use sterile water or appropriate buffer for dissolution

Research Applications:

• Study of multi-pathway anti-obesity treatments

• Investigation of glucose metabolism and insulin signaling

• Exploration of energy balance and fat oxidation

• Evaluation of peptide pharmacokinetics and receptor interactions.